Michael Ringel

Michael Ringel, COO of Life Biosciences and a seasoned expert with a PhD in biology, discusses groundbreaking advancements in cellular rejuvenation therapies. He delves into partial epigenetic reprogramming, dubbed the 'holy grail' for longevity, explaining how it rejuvenates cells while preserving functionality. The conversation touches on the promising ER-100 therapy aimed at combating vision loss and the collaborative spirit essential in biotech innovations. Ringel also emphasizes the potential of longevity interventions to tackle multiple age-related diseases simultaneously.